Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5

Iti Inc (ITCI US)

12
Analysis
Health CareUnited States
Intra-Cellular Therapies Inc. researches and develops biopharmaceutical drugs. The Company engages in the research and development of small molecule drugs to treat neuropsychiatric and neurological diseases and other disorders of the central nervous system. Intra-Cellular Therapies offers its products to the medical industry.
more
bullishIti Inc
27 Mar 2025 08:01

Intra-Cellular Therapies: These Are 5 Critical Challenges Threatening Its Expansion Plans!

Intra-Cellular Therapies' latest earnings results highlight a continued positive growth trajectory, driven primarily by the strong performance of...

Logo
333 Views
Share
bullishIti Inc
09 Nov 2024 19:00

Intra-Cellular Therapies Inc.: An Analysis Of The Commercial Strategy and Market Expansion for CAPLYTA & Key Growth Drivers

Intra-Cellular Therapies showcased robust financial and operational performance for the third quarter of 2024, spearheaded by the growth of their...

Logo
279 Views
Share
bullishIti Inc
20 Aug 2024 19:00

Intra-Cellular Therapies Inc.: Preparations for New Pipeline Developments and Indications! - Major Drivers

Intra-Cellular Therapies reported robust financial and operational results for the second quarter of 2024, underpinned by significant growth in...

Logo
183 Views
Share
22 Jan 2025 12:53Issuer-paid

Biopharma Week in Review - January 21, 2025

M&A and preannouncements led biopharma headlines last week, with nearly $20 billion in deals fueling some positive sentiment, but disappointing...

Logo
216 Views
Share
14 Jan 2025 13:34Issuer-paid

Biopharma Week in Review - January 13, 2025

As investors prepped for company updates and significant news flow, signs of M&A activity were trickling in, with BIIB bidding for SAGE, LLY...

Logo
196 Views
Share
x